Fumaric Acid

Fumaric Acid

SCHEMBL5868233

CC1(C)Oc2cc([N+](=O)[O-])ccc2[C@H](NCCc2ccccc2)[C@H]1O.O=C(O)C=CC(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KMT2A known ✓ Q03164 2/20 0.40
▸ MEN1 known ✓ O00255 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ GRIN2B Q13224 1/20 0.42
▸ KCNA5 P22460 6/20 0.42
▸ MAPT P10636 2/20 0.42
▸ PKM P14618 1/20 0.41
▸ ABCB1 P08183 3/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13199557 0.94 GRIN2B (0.47) SMN1; SMN2ALDH1A1HPGDGRIN2BKCNA5
SCHEMBL5991146 0.84 NPC1 (0.44) SMN1; SMN2ALDH1A1GRIN2BKCNA5MAPT
SCHEMBL2889411 0.84 NPC1 (0.44) SMN1; SMN2ALDH1A1GRIN2BKCNA5MAPT
SCHEMBL2889409 0.84 NPC1 (0.44) SMN1; SMN2ALDH1A1GRIN2BKCNA5MAPT
Fumaric Acid SCHEMBL2889022 0.81 KCNA5 (0.44) ALDH1A1KCNA5ABCB1TAAR1
Maleic Acid SCHEMBL2889017 0.81 KCNA5 (0.44) ALDH1A1KCNA5ABCB1TAAR1
Maleic Acid SCHEMBL2889020 0.81 KCNA5 (0.44) ALDH1A1KCNA5ABCB1TAAR1
SCHEMBL13476148 0.80 KCNA5 (0.42) SMN1; SMN2ALDH1A1HPGDGRIN2BKCNA5
SCHEMBL13476266 0.80 KCNH2 (0.45) SMN1; SMN2ALDH1A1KCNA5MAPTPKM
SCHEMBL13476183 0.80 KCNA5 (0.46) SMN1; SMN2ALDH1A1HPGDGRIN2BKCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7041700-B2 Substituted benzopyran derivatives against arrhythmia NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2006-05-09 — — US disclosed
US-20040152763-A1 Substituted benzopyran derivatives against arrhythmia NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2004-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152763-A1 Substituted benzopyran derivatives against arrhythmia CBR1, KCNH1, SCN8A KMT2A 2405/4885MEN1 3836/4885SMN1; SMN2 2521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback